Bijan Salehizadeh

Bijan has over 15 years of operational and investment experience in healthcare IT and products. He currently serves as managing director and co-founder at NaviMed Capital, a private investment firm based in Washington, DC where he focuses on growth venture capital healthcare investments in healthcare IT / analytics and healthcare services. Prior to co-founding NaviMed, he was a General Partner at Highland Capital Partners, a multi-billion dollar investment firm where was responsible for leading many of the firm’s healthcare transactions over a decade. Prior to joining Highland in 2003, Bijan spent several years at Medtronic, a global medical products and solutions company. Before Medtronic, he was an early employee at and held a variety of senior management roles at HealthCentral, a venture capital-backed healthcare IT company that went public in 1999. He is currently on the board of directors and advisory committees of numerous healthcare data and products companies including Auris Surgical, Hyperion Therapeutics (IPO), kyruus, and Procured Health, and has sourced or been actively involved in investments in AVEO Oncology (IPO), Baronova, BÂRRX Medical (sold to Covidien), Conor Medsystems (IPO; sold to Johnson & Johnson), and Pharmaca Integrative Pharmacy. Bijan holds an A.B. in Molecular Biology from Princeton University, an M.D. and Master’s in Science in Healthcare Policy from Columbia University, and an M.B.A. from Harvard Business School. He is also a graduate of the Kauffman Fellows Program and has been published in several peer-reviewed journals.